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Of the 42 responding centers, 32 were public hospitals serving 39% of Spain's population representing 23% of nuclear medicine (NM) departments listed by the Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM) including some private centers not performing nuclear cardiology (NC). Broader sampling is frequently unfeasible due to high rates of nonresponse to online questionnaires and this shouldn't deter us from analyzing the answers received. Our survey's population is actually superior to other NC surveys. 1, 2 Regarding radiation exposure, the 16% of centers using thallium did so only for particular settings (viability). The use of appropriate use criteria (AUC) is commonplace in Spain where the NC Working Group of SEMNIM has advocated AUC for many years and recently launched a multicentric national trial assessing its use. In the INCAPS study 3 the dose for southern Europe (Italy, Portugal, and Spain) was not significantly different from central-northern Europe (Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Sweden, Switzerland, and United Kingdom), 8.39 ± 2.11 vs 8.19 ± 3.24 mSv, respectively, with some northern countries exhibiting values of 13.6 mSv while the highest value in Spain was 10.5 mSv. Use of stress-only in Spain (60%), is superior to mean INCAPS 3 values (46% Europe, 16% North America, 30% total).
Relative to communication between NM physicians and cardiologists, 79% of centers had a cardiologist present during the stress procedure (33% alone and 46% together with a NM physician). The report being written solely by the NM physician in 70% of centers doesn´t imply the absence of intense communication with the cardiologist regarding the stress procedure and the image findings. 
